Original Research

Published on 09 Oct 2024

Sorbaria sorbifolia flavonoid derivative induces mitochondrial apoptosis in human hepatoma cells through Bclaf1

in Pharmacology of Anti-Cancer Drugs

Jiaxin Chen
Haoyi Cheng
Chunhua Bai
Dandan Wang
Jinghao Fu
Jinge Hao
Yixuan Wang
Zhang Xuewu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1459520

387 views

Original Research

Published on 08 Oct 2024

KHSRP knockdown inhibits papillary renal cell carcinoma progression and sensitizes to gemcitabine

in Pharmacology of Anti-Cancer Drugs

Wei Song
Heng Zhang
Yi Lu
Houliang Zhang
Jinliang Ni
Lan Chang
Yongzhe Gu
Guangchun Wang
Tianyuan Xu
Zonglin Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1446920

595 views

Original Research

Published on 08 Oct 2024

Multiple cell-death patterns predict the prognosis and drug sensitivity of melanoma patients

in Pharmacology of Anti-Cancer Drugs

Zewei Chen
Ruopeng Zhang
Zhoukai Zhao
Baiwei Zhao
Feiyang Zhang
Guoming Chen
Xiaojiang Chen
Chengzhi Wei
Jun Lin
Feizhi Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1295687

944 views

Brief Research Report

Published on 08 Oct 2024

T-cell engagers: model interrogation as a tool to quantify the interplay of relative affinity and target expression on trimer formation

in Pharmacology of Anti-Cancer Drugs

Massimo Lai
Cesar Pichardo-Almarza
Meghna Verma
Md Shahinuzzaman
Xu Zhu
Holly Kimko

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470595

594 views

Original Research

Published on 02 Oct 2024

The baseline hemoglobin level is a positive biomarker for immunotherapy response and can improve the predictability of tumor mutation burden for immunotherapy response in cancer

in Pharmacology of Anti-Cancer Drugs

Yin He
Tong Ren
Chengfei Ji
Li Zhao
Xiaosheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1456833

511 views

Original Research

Published on 02 Oct 2024

Dehydroepiandrosterone suppresses human colorectal cancer progression through ER stress-mediated autophagy and apoptosis in a p53-independent manner

in Pharmacology of Anti-Cancer Drugs

Thi-Huong Nguyen
Huey-Jiun Ko
Po-Yu Tsai
Tai-Shan Cheng
Thu-Ha Tran
Ly Hien Doan
Michael Hsiao
Peter Mu-Hsin Chang
Hsiao-Sheng Liu
Yi-Ren Hong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464647

600 views

Original Research

Published on 02 Oct 2024

DNA methylation inhibitors adverse reaction characteristic analysis: a descriptive analysis from WHO-VigiAccess

in Pharmacology of Anti-Cancer Drugs

Qiang Zhou
Quanlei Xie
Qiang Liu
Haojie Wang
Zhan Zhang
Zhao Yu
Qian Guo
Jie Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470148

505 views

Mini Review

Published on 01 Oct 2024

Assessment of ferroptosis as a promising candidate for metastatic uveal melanoma treatment and prognostication

in Pharmacology of Anti-Cancer Drugs

Ellie Swords
Breandán N. Kennedy
Valentina Tonelotto

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466896

690 views

Review

Published on 01 Oct 2024

RGD-based self-assembling nanodrugs for improved tumor therapy

in Pharmacology of Anti-Cancer Drugs

Bin Wang
Dongmei Tang
Jianqiao Cui
Hongfei Jiang
Jing Yu
Zhu Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477409

398 views

Review

Published on 30 Sep 2024

The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy

in Pharmacology of Anti-Cancer Drugs

Yujing Tang
Wantao Ju
Yanjun Liu
Qin Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469830

885 views

Correction

Published on 30 Sep 2024

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis

in Pharmacology of Anti-Cancer Drugs

Burhan Ul Haq
Hina Qayoom
Shazia Sofi
Nusrat Jan
Aisha Shabir
Irshad Ahmad
Fuzail Ahmad
Abdullah Almilaibary
Manzoor A. Mir

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494110

199 views

Original Research

Published on 27 Sep 2024

Interstitial lung disease associated with ALK inhibitors and risk factors: an updated comparative pharmacovigilance analysis

in Pharmacology of Anti-Cancer Drugs

Junli Dong
Lulu Li
Tiying Deng
Haibin Song
Shaohui Zhang
Minyu Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361443

835 views

Review

Published on 27 Sep 2024

Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches

in Pharmacology of Anti-Cancer Drugs

Haoyang Chen
Huihui Liu
Xiaowei Zhang
Suhua Wang
Chunxia Liu
Ke An
Ruijuan Liu
Xin Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422033

532 views

Perspective

Published on 26 Sep 2024

Erbin: an important therapeutic target for blocking tumor metastasis

in Pharmacology of Anti-Cancer Drugs

Tingting Qiu
Liquan Tan
Jialong Yan
Qunli Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474798

694 views

Case Report

Published on 26 Sep 2024

A case report: deep and durable response to low-dose lenvatinib and tislelizumab in an elderly patient with advanced intrahepatic cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Pei Zhang
Xin Wang
Ruizhen Li
Xiaoying Li
Ke Cheng
Dan Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447582

540 views

Original Research

Published on 25 Sep 2024

Global trends and topics in CDK7 inhibitor research: a bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Jiamin Liu
Ling He
Wenjing Jiang
Ping Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426988

645 views

Navigation group

Articles

Sorbaria sorbifolia flavonoid derivative induces mitochondrial apoptosis in human hepatoma cells through Bclaf1

KHSRP knockdown inhibits papillary renal cell carcinoma progression and sensitizes to gemcitabine

Multiple cell-death patterns predict the prognosis and drug sensitivity of melanoma patients

T-cell engagers: model interrogation as a tool to quantify the interplay of relative affinity and target expression on trimer formation

The baseline hemoglobin level is a positive biomarker for immunotherapy response and can improve the predictability of tumor mutation burden for immunotherapy response in cancer

Dehydroepiandrosterone suppresses human colorectal cancer progression through ER stress-mediated autophagy and apoptosis in a p53-independent manner

DNA methylation inhibitors adverse reaction characteristic analysis: a descriptive analysis from WHO-VigiAccess

Assessment of ferroptosis as a promising candidate for metastatic uveal melanoma treatment and prognostication

RGD-based self-assembling nanodrugs for improved tumor therapy

The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis

Interstitial lung disease associated with ALK inhibitors and risk factors: an updated comparative pharmacovigilance analysis

Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches

Erbin: an important therapeutic target for blocking tumor metastasis

A case report: deep and durable response to low-dose lenvatinib and tislelizumab in an elderly patient with advanced intrahepatic cholangiocarcinoma

Global trends and topics in CDK7 inhibitor research: a bibliometric analysis